11%, p < 0.001) and a statistical trend towards older age and longer disease duration.
← all excerpts
Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review.
1
—
—
11%, p < 0.001) and a statistical trend towards older age and longer disease duration.